MedPath

Assessment the efficacy of rotator cuff injection of Platelet Rich Plasma in patients with partial tear of rotator cuff

Phase 2
Conditions
Rotator cuff tendon tear.
Rotator cuff syndrome
Registration Number
IRCT201011205214N1
Lead Sponsor
Vice chancellor for research Tehran university of medical science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

The inclusion criteria include: established rotator cuff tear (traumatic or degenerative) in MRI that should not be massive or full thickness in the radiologist report; shoulder pain or dysfunction in a severity level that patient look for medical intervention or candidate for surgery; all patients should have failed two-week treatments with NSAIDs and six weeks of physical therapy; Written informed consent.
The exclusion criteria include: pregnancy or active breast-feeding; presence of a tumor, metastatic disease, active infections; platelet count less than 100000 per µl or Hgb less than 10 g/dl; gross instability of the glenohumeral joint; superior labral lesions requiring surgical repair; patients with painful cervical spine pathology; previous surgery on the shoulder joint; national or international level athletes.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: before intervention, 4 weeks, 8weeks and 12weeks after intervention. Method of measurement: 10cm VAS.;Function. Timepoint: Before intervention, 4 weeks ,8weeks and 12weeks after intervention. Method of measurement: Constant score.
Secondary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: Before intervention, and 4 weeks ,8weeks and 12weeks after intervention. Method of measurement: WORC.
© Copyright 2025. All Rights Reserved by MedPath